CYCC: Cyclacel Pharmaceuticals Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Cyclacel Pharmaceuticals Inc (CYCC).
$2.36M Market Cap.
CYCC Market Cap. (MRY)
CYCC Shares Outstanding (MRY)
CYCC Assets (MRY)
Total Assets
$4.09M
Total Liabilities
$6.27M
Total Investments
$0
CYCC Income (MRY)
Revenue
$43.00K
Net Income
-$11.21M
Operating Expense
$12.05M
CYCC Cash Flow (MRY)
CF Operations
-$7.99M
CF Investing
$0
CF Financing
$7.82M
CYCC Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $4,094,000 (-53.50%) | $8,805,000 (-68.61%) | $28,050,000 (-34.97%) | $43,136,000 (17.21%) |
Assets Current | $3,674,000 (-50.64%) | $7,444,000 (-69.51%) | $24,411,000 (-40.38%) | $40,942,000 (15.43%) |
Assets Non-Current | $420,000 (-69.14%) | $1,361,000 (-62.60%) | $3,639,000 (65.86%) | $2,194,000 (64.59%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | -$2,174,000 (-458.15%) | $607,000 (-96.19%) | $15,939,000 (-57.71%) | $37,693,000 (13.33%) |
Property Plant & Equipment Net | $8,000 (-92.16%) | $102,000 (-41.38%) | $174,000 (85.11%) | $94,000 (-92.95%) |
Cash & Equivalents | $3,137,000 (-7.13%) | $3,378,000 (-81.59%) | $18,345,000 (-49.82%) | $36,559,000 (9.44%) |
Accumulated Other Comprehensive Income | -$891,000 (1.87%) | -$908,000 (31.00%) | -$1,316,000 (-75.94%) | -$748,000 (-0.27%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $4,599,000 (29.81%) | $3,543,000 (38.34%) | $2,561,000 (20.97%) | $2,117,000 (311.87%) |
Accumulated Retained Earnings (Deficit) | -$439,494,000 (-2.62%) | -$428,282,000 (-5.56%) | -$405,727,000 (-5.51%) | -$384,529,000 (-5.04%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $0 (0%) | $37,000 (-65.09%) | $106,000 (253.33%) | $30,000 (-97.16%) |
Debt Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Debt Non-Current | $0 (0%) | $37,000 (-65.09%) | $106,000 (253.33%) | $30,000 (-97.16%) |
Total Liabilities | $6,268,000 (-23.54%) | $8,198,000 (7.63%) | $7,617,000 (39.94%) | $5,443,000 (53.63%) |
Liabilities Current | $6,268,000 (-23.20%) | $8,161,000 (8.65%) | $7,511,000 (38.76%) | $5,413,000 (117.74%) |
Liabilities Non-Current | $0 (0%) | $37,000 (-65.09%) | $106,000 (253.33%) | $30,000 (-97.16%) |
CYCC Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $43,000 (-89.76%) | $420,000 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $5,392,000 (-19.74%) | $6,718,000 (-8.99%) | $7,382,000 (-1.06%) | $7,461,000 (26.95%) |
Research & Development Expense | $6,655,000 (-65.26%) | $19,155,000 (-5.52%) | $20,274,000 (35.81%) | $14,928,000 (213.68%) |
Operating Expenses | $12,047,000 (-53.44%) | $25,873,000 (-6.45%) | $27,656,000 (23.52%) | $22,389,000 (110.50%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | -$782,000 (73.90%) | -$2,996,000 (36.49%) | -$4,717,000 (-26.53%) | -$3,728,000 (-201.62%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$11,212,000 (50.29%) | -$22,555,000 (-6.40%) | -$21,198,000 (-14.85%) | -$18,457,000 (-118.56%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$11,212,000 (50.29%) | -$22,555,000 (-6.40%) | -$21,198,000 (-14.85%) | -$18,457,000 (-118.56%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $201,000 (0.00%) | $201,000 (0.00%) | $201,000 (-94.94%) |
Net Income Common Stock | -$11,212,000 (50.73%) | -$22,756,000 (-6.34%) | -$21,399,000 (-14.69%) | -$18,658,000 (-50.21%) |
Weighted Average Shares | $26,197 (645.93%) | $3,512 (12.31%) | $3,127 (26.14%) | $2,479 (145.69%) |
Weighted Average Shares Diluted | - | - | $3,127 (26.14%) | $2,479 (145.69%) |
Earning Before Interest & Taxes (EBIT) | -$11,994,000 (53.06%) | -$25,551,000 (1.40%) | -$25,915,000 (-16.81%) | -$22,185,000 (-129.16%) |
Gross Profit | $43,000 (-89.76%) | $420,000 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$12,004,000 (52.84%) | -$25,453,000 (7.97%) | -$27,656,000 (-23.52%) | -$22,389,000 (-110.50%) |
CYCC Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $0 (0%) | -$6,000 (14.29%) | -$7,000 (74.07%) | -$27,000 (71.88%) |
Net Cash Flow from Financing | $7,822,000 (822.41%) | $848,000 (-71.71%) | $2,998,000 (-86.21%) | $21,737,000 (-26.33%) |
Net Cash Flow from Operations | -$7,990,000 (50.41%) | -$16,112,000 (22.64%) | -$20,827,000 (-12.34%) | -$18,540,000 (-133.68%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$241,000 (98.39%) | -$14,967,000 (17.83%) | -$18,214,000 (-677.67%) | $3,153,000 (-85.35%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | $0 (0%) | -$6,000 (14.29%) | -$7,000 (74.07%) | -$27,000 (71.88%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $7,822,000 (645.66%) | $1,049,000 (-67.21%) | $3,199,000 (-85.42%) | $21,938,000 (-26.15%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | -$73,000 (-124.09%) | $303,000 (180.16%) | -$378,000 (-2123.53%) | -$17,000 (-136.17%) |
Share Based Compensation | $592,000 (-59.81%) | $1,473,000 (-2.19%) | $1,506,000 (30.16%) | $1,157,000 (169.07%) |
Depreciation Amortization & Accretion | $6,000 (-80.65%) | $31,000 (-3.13%) | $32,000 (-25.58%) | $43,000 (115.00%) |
CYCC Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 100.00% (0.00%) | 100.00% | - | - |
Profit Margin | -26074.40% (-381.25%) | -5418.10% | - | - |
EBITDA Margin | -27879.10% (-358.82%) | -6076.20% | - | - |
Return on Average Equity (ROAE) | 1030.80% (328.61%) | -450.90% (-435.51%) | -84.20% (-92.24%) | -43.80% (16.57%) |
Return on Average Assets (ROAA) | -188.20% (-23.65%) | -152.20% (-138.18%) | -63.90% (-59.35%) | -40.10% (14.32%) |
Return on Sales (ROS) | -27893.00% (-358.49%) | -6083.60% | - | - |
Return on Invested Capital (ROIC) | 249.70% (-96.88%) | 8016.00% (913.97%) | -984.80% (52.64%) | -2079.20% (-566.41%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -0.18 (-80.00%) | -0.1 (71.35%) | -0.35 (81.25%) | -1.86 (18.52%) |
Price to Sales Ratio (P/S) | 54.98 (926.05%) | 5.36 | - | - |
Price to Book Ratio (P/B) | -1.09 (-129.32%) | 3.71 (606.10%) | 0.53 (-48.98%) | 1.03 (-9.89%) |
Debt to Equity Ratio (D/E) | -2.88 (-121.35%) | 13.51 (2725.52%) | 0.48 (231.94%) | 0.14 (34.58%) |
Earnings Per Share (EPS) | -501.6 (92.19%) | -6,420 (6.79%) | -6,888 (8.45%) | -7,524 (38.89%) |
Sales Per Share (SPS) | 1.64 (-98.63%) | 119.59 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -305 (93.35%) | -4,589.55 (31.12%) | -6,663.52 (11.01%) | -7,488.22 (5.88%) |
Book Value Per Share (BVPS) | -82.99 (-148.01%) | 172.84 (-96.61%) | 5,097.91 (-66.47%) | 15,201.9 (-53.87%) |
Tangible Assets Book Value Per Share (TABVPS) | 156.28 (-93.77%) | 2,507.19 (-72.05%) | 8,971.47 (-48.43%) | 17,397.1 (-52.29%) |
Enterprise Value Over EBIT (EV/EBIT) | 0 (0%) | 0 (0%) | 1 (0%) | 0 (0%) |
Enterprise Value Over EBITDA (EV/EBITDA) | 0.05 (-63.64%) | 0.14 (-75.72%) | 0.59 (850.00%) | 0.06 (103.76%) |
Asset Turnover | 0.01 (-75.00%) | 0.03 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 0.59 (-35.75%) | 0.91 (-71.94%) | 3.25 (-57.03%) | 7.56 (-46.98%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$7,990,000 (50.43%) | -$16,118,000 (22.64%) | -$20,834,000 (-12.21%) | -$18,567,000 (-131.22%) |
Enterprise Value (EV) | -$618,011 (83.03%) | -$3,641,578 (76.10%) | -$15,235,361 (-1010.67%) | -$1,371,723 (-108.62%) |
Earnings Before Tax (EBT) | -$11,994,000 (53.06%) | -$25,551,000 (1.40%) | -$25,915,000 (-16.81%) | -$22,185,000 (-129.16%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$11,988,000 (53.03%) | -$25,520,000 (1.40%) | -$25,883,000 (-16.90%) | -$22,142,000 (-129.19%) |
Invested Capital | -$5,311,000 (-96.92%) | -$2,697,000 (-217.26%) | $2,300,000 (92.63%) | $1,194,000 (-39.30%) |
Working Capital | -$2,594,000 (-261.79%) | -$717,000 (-104.24%) | $16,900,000 (-52.43%) | $35,529,000 (7.72%) |
Tangible Asset Value | $4,094,000 (-53.50%) | $8,805,000 (-68.61%) | $28,050,000 (-34.97%) | $43,136,000 (17.21%) |
Market Capitalization | $2,363,989 (5.05%) | $2,250,422 (-73.09%) | $8,363,639 (-78.45%) | $38,803,277 (2.15%) |
Average Equity | -$1,087,750 (-121.55%) | $5,047,000 (-80.13%) | $25,405,750 (-40.33%) | $42,580,500 (79.92%) |
Average Assets | $5,957,500 (-60.15%) | $14,951,000 (-55.39%) | $33,511,500 (-28.04%) | $46,571,500 (75.46%) |
Invested Capital Average | -$4,804,000 (-1407.14%) | -$318,750 (-112.11%) | $2,631,500 (146.63%) | $1,067,000 (-65.62%) |
Shares | 26,197 (645.93%) | 3,512 (0.83%) | 3,483 (25.69%) | 2,771 (105.11%) |
